From STAT: Scott Gottlieb, Trump’s pick to lead the FDA, should consider pursuing a stronger warning label for the antidepressant Paxil. Paxil’s label currently does not indicate any risk of suicidal behavior for anyone over 25, even though there is scientific evidence that such a risk is real.
